✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceLU-003
Loading study workspace…
3D Tumour Intelligence

LU-003

QC ReviewRESEARCH MODE

NSCLC PROTAC Response Study

AssetOGC-LU-104CancerLung CancerSubtypeNSCLCModel3D Tumour SpheroidLead ScientistDr. A. Kumar
Review DiscussionAsk OSIEL About This Study

Study Summary

Scientific context and protocol

Target degradation may suppress NSCLC spheroid growth.

Linked AssetOGC-LU-104
Cancer / SubtypeLung Cancer · NSCLC
Model3D Tumour Spheroid
InvestigatorsDr. Sarah Mokoena · Dr. J. Patel
ProtocolOG-PROT-3D-030
Start Date2026-09-20
Current StageQC Review
Data ModeRESEARCH

Key Result

Day 7 response · illustrative scientific data

DRUG B

Analysis Pending

Study has not reached final response analysis.

ViabilityPending
Tumour sizePending
ConfidencePending

Treatment Overview

Control and two intervention groups

Control0 · 3 replicates
Drug A0.1 µM · 3 replicates
Drug B0.8 µM · 3 replicates

Timepoints

Longitudinal image and response capture

Day 0Day 3Day 7

Current analytical timepoint: Not yet analysed.

Study Timeline

Completed, current, and upcoming workflow

Setup
Samples
Treatment
Imaging
Segmentation & QC
Response Analysis
Scientific Review
Approved Result

Current Alerts

Research review required

QC Review review pendingNeeds Review
Needs Review QC status requires confirmationNeeds Review

Study Context

Current scientific record

StageQC Review
QCNeeds Review
ProtocolOG-PROT-3D-030
Images78
Last Updated2026-09-30

Current Attention

Research review queue

QC Review review pendingNeeds Review QC status requires confirmation
Research data · human review required.